Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
42.25%
operating margin TTM
43.61%
revenue TTM
997.15 Million
revenue per share TTM
12.42$
valuation ratios | |
|---|---|
| pe ratio | 8.20 |
| peg ratio | 0.41 |
| price to book ratio | -39.58 |
| price to sales ratio | 3.55 |
| enterprise value multiple | 7.30 |
| price fair value | -39.58 |
profitability ratios | |
|---|---|
| gross profit margin | 99.66% |
| operating profit margin | 43.61% |
| pretax profit margin | 41.65% |
| net profit margin | 42.25% |
| return on assets | 28.43% |
| return on equity | -182.66% |
| return on capital employed | 43.65% |
liquidity ratios | |
|---|---|
| current ratio | 2.32 |
| quick ratio | 2.26 |
| cash ratio | 0.78 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 3,198.79 |
| operating cycle | 3,240.45 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 3,240.45 |
| receivables turnover | 8.76 |
| payables turnover | 0.00 |
| inventory turnover | 0.11 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.16 |
| debt equity ratio | -2.63 |
| long term debt to capitalization | -2.35 |
| total debt to capitalization | 1.61 |
| interest coverage | 5.62 |
| cash flow to debt ratio | 1.74 |
cash flow ratios | |
|---|---|
| free cash flow per share | 8.95 |
| cash per share | 21.51 |
| operating cash flow per share | 9.12 |
| free cash flow operating cash flow ratio | 0.98 |
| cash flow coverage ratios | 1.74 |
| short term coverage ratios | 2.38 |
| capital expenditure coverage ratio | 55.11 |
Frequently Asked Questions
When was the last time PTC Therapeutics, Inc. (NASDAQ:PTCT) reported earnings?
PTC Therapeutics, Inc. (PTCT) published its most recent earnings results on 04-11-2025.
What is PTC Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. PTC Therapeutics, Inc. (NASDAQ:PTCT)'s trailing twelve months ROE is -182.66%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. PTC Therapeutics, Inc. (PTCT) currently has a ROA of 28.43%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PTCT's net profit margin stand at?
PTCT reported a profit margin of 42.25% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PTCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.32 in the most recent quarter. The quick ratio stood at 2.26, with a Debt/Eq ratio of -2.63.